Patents by Inventor J. Peter Fuhrer

J. Peter Fuhrer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prophylactic and therapeutic benefits of a new class of immune stimulating peptides
    Patent number: 7358044
    Abstract: A new class of lipopeptides has been surprisingly discovered from mammalian serum that are potent immunoregulators, hereinafter, referred to as Immune Cell Potentiating Factors (“ICPF”s). The clinical and laboratory data show a wide range of prophylactic and therapeutic applications for the ICPFs including primary and adjunctive therapy in the treatment of diseases of both bacterial and viral origin as well as certain neoplastic diseases. Described herein are chemical structures of ICPF of the invention, the likely mode of action, and the surprisingly broad spectrum of therapeutic efficacy and wide margin of safety to the host species.
    Type: Grant
    Filed: April 16, 2004
    Date of Patent: April 15, 2008
    Assignee: Argyll Biotechnologies, LLC.
    Inventors: James D. Thacker, J. Peter Fuhrer, Kenneth O. Willeford
  • Anti-inflammatory factor, method of isolation, and use
    Patent number: 5980953
    Abstract: The invention relates to an anti-inflammatory factor isolated from milk, methods of purifying the anti-inflammatory factor resulting in substantially or highly purified preparations and to methods for using this factor to remove adhered neutrophils from endothelial cells, to prevent the emigration of cells from the vasculature and to suppress the response of lymphocytes to foreign antigens.
    Type: Grant
    Filed: July 22, 1997
    Date of Patent: November 9, 1999
    Assignee: Stolle Milk Biologics, Inc.
    Inventors: Lee R. Beck, J. Peter Fuhrer
  • Anti-inflammatory factor, method of isolation, and use
    Patent number: 5650175
    Abstract: The invention relates to an anti-inflammatory factor isolated from milk, methods of purifying the anti-inflammatory factor resulting in substantially or highly purified preparations and to methods for using this factor to remove adhered neutrophils from endothelial cells, to prevent the emigration of cells from the vasculature and to suppress the response of lymphocytes to foreign antigens.
    Type: Grant
    Filed: October 3, 1994
    Date of Patent: July 22, 1997
    Assignee: Stolle Research & Development Corporation
    Inventors: Lee R. Beck, J. Peter Fuhrer